首页> 外文OA文献 >Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

【2h】

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

机译：基于特拉法韦的三联疗法在丙型肝炎病毒肝移植患者中的应用：一项为期12周的初步研究，提供了安全性和有效性数据

页面导航

著录项
相似文献
相关主题

著录项

作者
Werner Christoph R.; Egetemeyr Daniel; Lauer Ulrich Manfred; Nadalin Silvio; Malek Nisar Peter; Berg Christoph Peter; Königsrainer Alfred;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data [J] . Werner C.R., Egetemeyr D.P., Lauer U.M., Liver transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society . 2012 ,第12期

机译：基于特拉法韦的三联疗法治疗丙型肝炎病毒的肝移植患者：为期12周的初步研究提供了安全性和有效性数据
2. Safety of Direct-Acting Antiviral Therapy Regarding Renal Function in Post-Liver Transplant Patients Infected with Hepatitis C Virus and a 100% 12-Week Sustained Virologic Response-A Single-Center Study [J] . Peschel G., Moleda L., Baier L., Transplantation Proceedings . 2018 ,第5期

机译：对肝癌后移植患者肾功能的直接作用抗病毒治疗的安全性，100％12周持续的病毒反应 - 单中心研究
3. Daily Low-dose Tacrolimus Is a Safe and Effective Immunosuppressive Regimen During Telaprevir-based Triple Therapy for Hepatitis C Virus Recurrence After Liver Transplant [J] . Papadopoulos-Koehn Angela, Achterfeld Anne, Paul Andreas, Transplantation: Official Journal of the Transplantation Society . 2015 ,第4期

机译：每日小剂量他克莫司是一种基于特拉法韦的肝移植后丙型肝炎病毒复发三联疗法的安全有效的免疫抑制方案。
4. IMANI-1 TC3WP Single Drug HAART -Proof of Concept Study Pilot Study of the Safety and Efficacy of Kaletra (LPV/r) as Single Drug HAART in HIV+ ARV- Naive Patients - Interim Analysis of Subjects Completing Final 48 Week Data [C] . J.C. Gathe Jr., M. Washington, C. Mayberry International AIDS Conference . 2004

机译：Imani-1 TC3WP单药搭载概念研究试验试验研究Kaletra（LPV / R）作为艾滋病毒+ ARV天真患者单药HAART的安全性和有效性 - 临时分析受试者完成最终的48周数据
5. The efficacy of a triple medication therapy to prevent recurrent Hepatitis C post liver transplantation: A pilot study. [D] . Strutynski, Katherine M. 2011

机译：一项三联药物治疗预防肝移植后复发丙型肝炎的功效。
6. Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results [O] . Christoph R. Werner, Daniel P. Egetemeyr, Ulrich M. Lauer, -1

机译：基于特拉法韦的三联疗法在丙型肝炎病毒肝移植患者中的可行性：SVR 24结果
7. Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 results. [O] . Christoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, 2013

机译：丙型肝炎病毒肝移植患者中基于筛选的三联疗法的可行性：sVR 24结果。

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

著录项

相似文献

相关主题

期刊订阅